that doesn’t include trial costs. Once trials start there will be higher spends for a few months IMO.
On the back of this if we can get partnerships for future funding that will be great.
Ann: Quarterly activities and cashflow report, page-3
Add COV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.015(4.55%) |
Mkt cap ! $28.15M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 35.0¢ | 34.0¢ | $43.28K | 124.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17837 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 15.52pm 24/07/2024 (20 minute delay) ? |
| COV (ASX) Chart |